Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients

Study of Usefulness of Presepsin as Early Detective Marker of Sepsis in Immunodeficiency ICU Patients

This is an observational study to evaluate the diagnostic and prognostic value of presepsin in the critically-ill immunocompromise patients.

Inclusion Criteria:

• Male or female aged ≥ 19 years
• Appropriate clinical data to enable classification into sepsis
• Written informed consent by the patient or legally authorized representative
• Critical illness consistent with sepsis, to be enrolled within 24 hours of presentation

Exclusion Criteria:

• No informed consent
• A patient who is judged to be unable to make a voluntary decision by understanding information about this research due to cognitive vulnerability